Net Cash Provided by (Used in) Investing Activities of BriaCell Therapeutics Corp. from 31 Jul 2024 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
BriaCell Therapeutics Corp. quarterly and annual Net Cash Provided by (Used in) Investing Activities in USD history and change rate from 31 Jul 2024 to 31 Oct 2025.
  • BriaCell Therapeutics Corp. Net Cash Provided by (Used in) Investing Activities for the quarter ending 31 Oct 2025 was $75,000, unchanged year-over-year.
  • BriaCell Therapeutics Corp. annual Net Cash Provided by (Used in) Investing Activities for 2025 was $7,646,000, a 1021% decline from 2024.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Change (%)

BriaCell Therapeutics Corp. Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $75,000 $0 0% 01 Aug 2025 31 Oct 2025 10-Q 11 Dec 2025 2026 Q1
Q3 2024 $75,000 01 Aug 2024 31 Oct 2024 10-Q 11 Dec 2025 2026 Q1

BriaCell Therapeutics Corp. Annual Net Cash Provided by (Used in) Investing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $7,646,000 -$6,964,199 -1021% 01 Aug 2024 31 Jul 2025 10-K 16 Oct 2025 2025 FY
2024 $681,801 01 Aug 2023 31 Jul 2024 10-K 16 Oct 2025 2025 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.